SCHEMBL6660154

SCHEMBL6660154

CC(C)(CCNC(=O)OC(C)(C)C)CC(=O)N(C#N)C1CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.40
TDP1 Q9NUW8 1/20 0.37
CTSK P43235 6/20 0.36
CTSS P25774 6/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
GAA P10253 1/20 0.35
CTSL P07711 2/20 0.34
CTSB P07858 2/20 0.34
CHRM2 P08172 2/20 0.34
CHRM4 P08173 2/20 0.34
CHRM5 P08912 2/20 0.34
CHRM1 P11229 2/20 0.34
CHRM3 P20309 2/20 0.34
ALDH1A1 P00352 1/20 0.33
TSHR P16473 1/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
CTSD P07339 1/20 0.33
CA12 O43570 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6657074 0.95 EPHX1 (0.43) EPHX1TDP1CTSKCTSSMEN1
SCHEMBL18770579 0.71 TDP1 (0.47) EPHX1TDP1CTSKCTSSMEN1
SCHEMBL24899376 0.71 MEN1 (0.56) EPHX1TDP1MEN1KMT2AGAA
SCHEMBL6048166 0.70 CTSK (0.38) EPHX1CTSKCTSSMEN1KMT2A
SCHEMBL3924144 0.70 TDP1 (0.49) EPHX1TDP1MEN1KMT2AGAA
SCHEMBL24899380 0.69 TDP1 (0.45) EPHX1TDP1CTSKMEN1KMT2A
SCHEMBL4325775 0.68 TDP1 (0.50) EPHX1TDP1CTSKCTSSMEN1
SCHEMBL2713175 0.68 CTSK (0.37) EPHX1CTSKCTSSMEN1KMT2A
SCHEMBL21687368 0.67 TDP1 (0.53) EPHX1TDP1CTSKCTSSMEN1
SCHEMBL1164569 0.67 TDP1 (0.58) EPHX1TDP1MEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1434769-A2 COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2004-07-07 EP disclosed
WO-2003029200-A2 COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2003-04-10 WO disclosed